Literature DB >> 16319105

Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis.

T Matsuzaki1, A Nakajima, S Ishigami, M Tanno, S Yoshino.   

Abstract

OBJECTIVES: To examine the effect of mirthful laughter in rheumatoid arthritis (RA), we evaluated the levels of serum cytokines before and after patients experienced mirthful laughter.
METHODS: Forty-one patients with RA and 23 healthy subjects were enrolled. They listened to 'Rakugo', a traditional Japanese comic story, to induce mirthful laughter. We measured serum IL-6, IL-1beta, TNF-alpha, IL-4 and IL-1 receptor antagonist (IL-1Ra) concentrations before and after patients listened to the story. The RA subjects were divided into two groups. One was designated the 'difficult-to-control RA' group (CRP > or =1.0 mg/dl); The other group was regarded as the 'easily controlled RA' group (CRP <1.0 mg/dl).
RESULTS: The basal levels of serum IL-6 and TNF-alpha in the RA patients were significantly higher than those in the healthy group. After experiencing mirthful laughter, the levels of serum IL-6 decreased significantly in the RA group but not in the healthy subjects. Interestingly, the level of serum TNF-alpha decreased only in the easily controlled RA group. Serum IL-4 concentration in the RA group was significantly higher than that in healthy subjects before the story. After the story, the level of serum IL-4 significantly decreased in the RA group, especially in the difficult-to-control RA group. In contrast, serum IL-1Ra concentration was statistically higher in the RA group than that in healthy subjects before the story, and a further increase was observed after the story, especially in the easily controlled RA group.
CONCLUSIONS: Our findings suggest that mirthful laughter affects the levels of serum pro- and anti-inflammatory cytokines differentially, depending on the RA disease activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319105     DOI: 10.1093/rheumatology/kei081

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

Review 1.  'As above, so below' examining the interplay between emotion and the immune system.

Authors:  Samuel Brod; Lorenza Rattazzi; Giuseppa Piras; Fulvio D'Acquisto
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

2.  Humor in systemic lupus erythematosus.

Authors:  Cristiano S Moura; Rui Li; Sarah Lawrie; Amit Bar-Or; Ann E Clarke; Deborah Da Costa; Devi Banerjee; Sasha Bernatsky; Jennifer L Lee; Christian A Pineau
Journal:  Eur J Rheumatol       Date:  2015-03-01

3.  Behavioral Comorbidities in Rheumatoid Arthritis: A Psychoneuroimmunological Perspective.

Authors:  Michael R Irwin; Mary Davis; Alex Zautra
Journal:  Psychiatr Times       Date:  2008-08-01

Review 4.  Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications.

Authors:  Travis O Bruce
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

5.  Depression history, stress, and pain in rheumatoid arthritis patients.

Authors:  Alex J Zautra; Brendt P Parrish; Christina M Van Puymbroeck; Howard Tennen; Mary C Davis; John W Reich; Mike Irwin
Journal:  J Behav Med       Date:  2007-04-05

6.  Association between visual status and the frequency of laughter in older Japanese individuals: the JAGES cross-sectional study.

Authors:  Akira Inoue; Yoshimune Hiratsuka; Atsuhide Takesue; Jun Aida; Katsunori Kondo; Akira Murakami
Journal:  BMJ Open Ophthalmol       Date:  2022-03-23

7.  Enhanced reactivity to pain in patients with rheumatoid arthritis.

Authors:  Robert R Edwards; Ajay D Wasan; Clifton O Bingham; Joan Bathon; Jennifer A Haythornthwaite; Michael T Smith; Gayle G Page
Journal:  Arthritis Res Ther       Date:  2009-05-04       Impact factor: 5.156

8.  Laughter, humor and pain perception in children: a pilot study.

Authors:  Margaret Stuber; Sherry Dunay Hilber; Lisa Libman Mintzer; Marleen Castaneda; Dorie Glover; Lonnie Zeltzer
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-05       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.